• 1
    Hull KM, Drewe E, Aksentijevich I et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine 2002; 81: 34968.
  • 2
    Galon J, Aksentijevich I, McDermott F et al. TNFRSF1A mutations and autoinflammatory syndromes. Curr Opin Immunol 2000; 12: 47986.
  • 3
    Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17: 58699.
  • 4
    Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 2003; 15: 619.
  • 5
    McDermott MF, Aksentijevich I, Galon J et al. Germline mutations in the extracellular domains of the 55 kD TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97: 13344.
  • 6
    Siebert S, Amos N, Fielding CA et al. Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum 2005; 52: 128792.
  • 7
    Todd I, Radford PM, Draper-Morgan K-A et al. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. Immunology 2004: 113: 6579.
  • 8
    Aganna E, Hammond L, Hawkins PN et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum 2003; 48: 263244.
  • 9
    Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ. Prospective study of anti-tumor necrosis factor receptor superfamily 1A fusion protein, in tumor necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology 2003; 42: 2359.
  • 10
    Karenko L, Pettersson T, Roberts P. Autosomal dominant ‘‘Mediterranean fever’’ in a Finnish family. J Intern Med 1992; 232: 3659.
  • 11
    Nevala H, Karenko L, Stjernberg S et al. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever. Arthritis Rheum 2002; 46: 10616.
  • 12
    Stjernberg-Salmela S, Pettersson T, Karenko L et al. A novel tumor necrosis factor receptor mutation in a Finnish family with periodic fever syndrome. Scand J Rheumatol 2004; 33: 1404.
  • 13
    Dodé C, André M, Bienvenu T et al. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2002; 46: 21818.
  • 14
    Fink MP. Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care 2003; 9: 14351.
  • 15
    Poritz LS, Garver KI, Tillberg AF, Koltun WA. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 2004; 116: 148.
  • 16
    Ma TY, Iwamoto GK, Hoa NT et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004; 286: G36776.
  • 17
    Swabb EA, Hynes RA, Marnane WG et al. Intestinal filtration-secretion due to increased intraluminal pressure in rabbits. Am J Physiol 1982; 242: G6575.